Table 2. Clinical outcomes.

SD: standard deviation; n/s: not significant

	Placebo group (n=44)	Dutasteride group (n=43)	P-value
Time-to-remission, days, mean (±SD)
Fatigue	10.3 (±8.4)	5.5 (±3.2)	<0.001
Loss of taste or smell (ageusia or anosmia)	11.1 (±6.6)	5.6 (±4.0)	<0.001
Remission minus taste or smell loss	11.7 (±7.7)	7.0 (±2.9)	<0.001
Overall symptoms	16.3 (±8.3)	9.2 (±4.3)	<0.001
Clinical recovery, mean (±SD)
% fully clinically recovered on Day 7	57.5%	84.1%	0.03
% of clinical recovery on Day 1	34.2 (±21.4)	60.4 (±24.2)	<0.0001
% of clinical recovery on Day 2	52.9 (±21.3)	78.5 (±17.8)	<0.0001
% of clinical recovery on Day 3	66.8 (±20.7)	89.2 (±12.3)	<0.0001
% of clinical recovery at Day 7	82.9 (±15.0)	97.4 (±5.7)	<0.0001
Oxygen saturation, mean (±SD)
Day 0	95.4 ±1.4	96.0 ± 1.5	n/s (.21)
Day 7	95.7 ±2.0	97.0 ± 1.4	0.02
Day 14	96.2 ±1.4	97.5 ± 1.2	0.0012
D Day 7-0	+0.3	+1.3	0.047
D Day 14-0	+0.9	+1.3	n/s (.25)